东宝生物：公司正按计划稳步推进股票回购事项

Group 1 - The core viewpoint of the articles highlights the importance of share buybacks as a value management tool in the capital market, especially following the release of new policies that support stock repurchase initiatives [1] - The company Dongbao Biological Technology Co., Ltd. has actively implemented its share buyback plan, with a total repurchase amount exceeding 40 million RMB as of March 31, 2025 [1] - The share buyback plan aims to optimize incentive systems, enhance innovation culture, and maintain company value and shareholder rights, thereby boosting investor confidence [1] Group 2 - Dongbao Biological is committed to advancing its "Collagen+" strategy to build a premium collagen brand, focusing on extending the industrial chain and enhancing the value chain [2] - The company plans to deepen its development in the health industry through high-quality growth and innovation, while also improving its core competitiveness [2] - The strategic focus includes comprehensive planning across brand, market, innovation, service, investment, and management to solidify its leading position in the collagen industry [2]